MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 244 filers reported holding MYRIAD GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,154,000 | -17.8% | 72,926 | -4.4% | 0.01% | -20.0% |
| Q4 2017 | $2,621,000 | -45.8% | 76,317 | -42.9% | 0.01% | -50.0% |
| Q3 2017 | $4,838,000 | -17.6% | 133,729 | -41.2% | 0.02% | -25.9% |
| Q2 2017 | $5,874,000 | +34.6% | 227,329 | 0.0% | 0.03% | +35.0% |
| Q1 2017 | $4,364,000 | +5.7% | 227,329 | -8.2% | 0.02% | 0.0% |
| Q4 2016 | $4,127,000 | – | 247,617 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |